Iovance Biotherapeutics Reports Fourth Quarter and Full-Year 2018 Financial Results and Provides Corporate Update

Go back to Iovance Biotherapeutics Reports Fourth Quarter and Full-Year 2018 Financial Results and Provides Corporate Update
(NASDAQ: IOVA) Delayed: 10.64 +0.45 (4.42%)
Previous Close $10.19    52 Week High
Open $10.18    52 Week Low
Day High $10.80    P/E N/A 
Day Low $10.03    EPS
Volume 16,056,911